Pan-cancer and breast cancer–specific studies have found that tumors arising in individuals of African ancestry (AFA), particularly West African ancestry, are more likely to have somatic TP53 mutations and less likely to have somatic PIK3CA mutations than tumors arising in individuals of European ancestry (EUR; refs. 2–9). This evidence concerns the gene TP53 and breast cancer.